|
RPPH1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.425900E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.377370E-01 |
| Normal-vs-Stage2 |
3.432600E-01 |
| Normal-vs-Stage3 |
3.889000E-01 |
| Normal-vs-Stage4 |
5.814800E-01 |
| Stage1-vs-Stage2 |
7.977200E-01 |
| Stage1-vs-Stage3 |
7.650800E-01 |
| Stage1-vs-Stage4 |
9.103600E-02 |
| Stage2-vs-Stage3 |
6.731400E-01 |
| Stage2-vs-Stage4 |
2.465200E-01 |
| Stage3-vs-Stage4 |
3.336400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.076800E-01 |
| Normal-vs-AfricanAmerican |
2.168000E-01 |
| Normal-vs-Asian |
5.444400E-03 |
| Caucasian-vs-AfricanAmerican |
5.152500E-02 |
| Caucasian-vs-Asian |
1.204150E-02 |
| AfricanAmerican-vs-Asian |
5.045600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.094800E-01 |
| Normal-vs-Female |
1.076750E-01 |
| Male-vs-Female |
2.811400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.640000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.171200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.870400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.760500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.702800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.248400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.851600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.762000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.726000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.811630E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.094200E-02 |
| Classical-VS-Follicular |
8.733600E-01 |
| Classical-VS-Other |
3.749200E-01 |
| Classical-VS-Normal |
2.253200E-01 |
| Tall-VS-Follicular |
3.989800E-02 |
| Tall-VS-Other |
3.528800E-01 |
| Tall-VS-Normal |
2.301600E-01 |
| Follicular-VS-Other |
3.773800E-01 |
| Follicular-VS-Normal |
1.589600E-01 |
| Other-VS-Normal |
3.607400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.034600E-01 |
| Normal-vs-N1 |
4.616600E-01 |
| N0-vs-N1 |
9.909400E-01 |
|
|
